Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: Philip.Grieve@nhs.net
NUTS: UK
Internet address(es)
Main address: https://cmu.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHS framework agreement for the supply of Immunoglobulin.
Reference number: CM/PHS/13/5404
II.1.2) Main CPV code
33651520
II.1.3) Type of contract
Supplies
II.1.4) Short description
NHS framework agreement for the supply of Immunoglobulin. The framework will commence on 1.7.2017 for a period of 1 year until 30.6.2018, with options to extend for up to a further 36 months. Please refer to the Invitation to offer for a list of purchasing points.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
749 380 980.00
GBP
II.2) Description
Lot No: Lot 1
II.2.1) Title
Normal Human Immunoglobulin for Intravenous Use
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UKD
UKE
UKC
UKN
UKJ
UKK
UKH
UKI
UKF
UKG
Main site or place of performance:
Please see below.
II.2.4) Description of the procurement
The framework agreement is intended for use by the Department of Health, Public Health England and NHS in England. It may also be used by private sector contractors and agents working on behalf of the above. A list can be supplied on request.
II.2.5) Award criteria
Quality criterion: Available on request
/ Weighting: Available on request
Cost criterion: Price
/ Weighting: 70 %
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Normal Human Immunoglobulin for Subcutaneous Use
II.2.2) Additional CPV code(s)
33651520
II.2.3) Place of performance
NUTS code:
UKD
UKE
UKC
UKN
UKJ
UKK
UKH
UKI
UKF
UKG
Main site or place of performance:
Please see below.
II.2.4) Description of the procurement
The framework agreement is intended for use by the Department of Health, Public Health England and NHS in England. It may also be used by private sector contractors and agents working on behalf of the above. A list can be supplied on request.
II.2.5) Award criteria
Quality criterion: Available on request
/ Weighting: Available on request
Cost criterion: Price
/ Weighting: 70 %
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2017/S 058-107476
Section V: Award of contract
Lot No: 1
Contract No: 2017/S058-107476
Title: Normal Human Immunoglobulin for Intravenous Use
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
19/06/2017
V.2.2) Information about tenders
Number of tenders received: 7
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
See additional information at Section VI.3)
United Kingdom
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 616 752 924.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 2
Contract No: 2017S058-107476
Title: Normal Human Immunoglobulin for Subcutaneous Use
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
19/06/2017
V.2.2) Information about tenders
Number of tenders received: 4
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
See additional information at Section VI.3)
See additional information at Section VI.3)
UK
NUTS: UK
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 132 628 056.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Awarded Suppliers:
Lot 1: Biotest (UK) Ltd, Longbridge, Birmingham, (SME company); Grifols UK Ltd, Cambridge, (SME company); LFB Biopharmaceuticals, London, (SME company)
Lot 1 and Lot 2: Baxalta UK Ltd, London, (non SME company); Bio Products Laboratory Ltd, Elstree, Herts, (non SME company); CSL Behring UK Ltd (non SME company); Octapharma Ltd, Manchester, (non SME company).
VI.4) Procedures for review
VI.4.1) Review body
Secretary of State for Health acting as part of the Crown through the Commercials Medicines Unit
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
VI.5) Date of dispatch of this notice
14/07/2017